Immutep IMMP
NASDAQ IMMP
$3.56 +0.10 (+2.89%)
As of: Nov 11, 2026 · 3:59 PM EST

Immutep (IMMP) Net Margin (2014 - 2017)

Updated

Immutep's Net Margin was -544.79% in the year ended Jun 30, 2026, up 49.85 percentage points from -594.64% a year earlier.

Analysis

Immutep (IMMP) Net Margin (2014 - 2017) Analysis & Trends

From the year ended Jun 30, 2009 onward, Immutep has reported Net Margin for 14 years.

  • Net Margin shows a four-year change of -544.77 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 marks the highest annual Net Margin since the year ended Jun 30, 2022.
  • Per Business Quant data, Net Margin in earlier years was -594.64% in the year ended Jun 30, 2025 and -0.02% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Immutep 252.65 Mn 41.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -366.03%
Mar 31, 2017 -129.02%
Jun 30, 2016 -1,468.42%
Mar 31, 2016 -687.45%
Jun 30, 2015 -19,101.30%
Jun 30, 2014 -83,767.85%
API Access

Immutep Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY